FDA inspection
Agilent Technologies Inc: FDA inspection ending May 6, 2026
FDA inspection 1319444 · No Action Indicated (NAI) · Boulder, CO
Key facts
| Inspection ID | 1319444 |
|---|---|
| Firm | Agilent Technologies Inc |
| FEI number | 3007057070 |
| Address | 5555 Airport Blvd |
| City | Boulder |
| State | CO |
| ZIP | 80301 |
| Country | United States |
| Fiscal year | 2026 |
| Inspection end date | May 6, 2026 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data